A New, Long-Acting HIV Prevention Drug Just Got FDA Approval

The Food and Drug Administration has approved a new form of pre-exposure prophylaxis (PrEP) for preventing cases of HIV. The treatment is called Apretude, and it's the first PrEP medication to be taken via injection instead as a once-daily pill. Apretude will only need to be taken once a month initially, then every...